In-stent restenosis (ISR), manifested as a 10 re-narrowing of the arterial lumen post-implantation of a 11 stent, is a detrimental limitation of stent technology. Under-12 standing and consequently devising ways of reducing the 13 frequency of ISR has been a continuing goal of research into 14 improved stent designs. The biological processes that can 15 lead to ISR have been found to be partially flow dependent 16 with the local hemodynamics at the arterial wall of crucial 17 importance. This paper investigates these biological processes 18 and their instigating factors. Furthermore, the history and 19 theory behind three stent technologies which endeavour to 20 reduce ISR rates through stent flow field augmentation are 21 presented: a flow divider which increases the blood-flow 22 velocity and consequently the wall shear stress through a 23 stented region, and two novel stent technologies which 24 induce helical flow that mimics the natural blood flow present 25 in healthy arteries. This paper serves as a thorough intro-26 duction to both the investigation of ISR, particularly the 27 influence of the local hemodynamics, and to the three novel 28 stent technologies which aim to reduce ISR rates.
INTRODUCTION

34
Cardiovascular disease (CVD) is currently one of 35 the leading causes of death in the developed world. In a 36 report published by the American Heart Association 37 (AHA) in February 2011 it was stated that CVD 38 accounted for 33.6% (813,804) of all 2,243,712 deaths 39 in the US in 2007. 114 CVD encompasses a spectrum of 40 diseases which affect the cardiovascular system 41 including hypertension, stroke and coronary artery 42 disease (CAD). CAD accounted for 49.9% of all 43 deaths due to CVD in the US in 2007. 114 In cases of 44 CAD, atherosclerotic lesions, typically formed in the 45 coronary arteries over the course of decades, narrow 46 the arterial lumen area, thereby reducing the flow of 47 blood, and consequently oxygen and nutrients, to tis-48 sue cells downstream.
49 Balloon angioplasty was developed by Charles 50 Dotter in the 1960s 31 as a minimally invasive treatment 51 for the arterial narrowing caused by atherosclerotic 52 lesions in the peripheral arteries, and later in the 1970 s 53 it was applied to renal, coronary and iliac arteries by 54 Gru¨ntzig and co-workers. [49] [50] [51] Re-blockage of a trea-55 ted coronary artery following this procedure, known as 56 restenosis, was reported in 30-60% of patients, 44 with 57 these patients consequently needing re-treatment with 58 either percutaneous methods or bypass surgery. 59 Restenosis following balloon angioplasty is attributed 60 to three key responses: acute elastic recoil, negative 61 wall remodelling (reduction in lumen area without a 62 change in wall mass) and arterial wall thickening into 63 the lumen (due to an increase in the number of cells 64 within the arterial wall). 65 Bare metal stents (BMS) were incorporated into the 66 angioplasty procedure in the 1990s to serve as a rigid 67 scaffold, thus eliminating elastic recoil and reducing 68 wall remodelling, 56 with some cases of positive 69 remodelling reported. 102 Even though stenting reduced 70 restenosis rates to between 22 and 32%, 37, 44, 126 it still 71 continued to be a burden. Restenosis with stents, 72 known as in-stent restenosis (ISR), is mostly due to 73 arterial wall thickening. Understanding and conse-74 quently devising ways of reducing the frequency of ISR 75 has been a continuing goal of research into improved 76 stent designs. From this research drug-eluting stents 77 (DES) were developed which use anti-proliferative, 78 immunosuppressive, pro-healing and anti-inflamma-79 tory drugs in an attempt to prevent ISR. DESs have Introduction 125 A diagram of a healthy arterial wall is given in 126 Fig. 1 ; however, the exact composition of a diseased 127 artery deviates from this ideal form. Stent implantation 128 has three effects on a treated artery: it induces struc-129 tural injury, introduces a foreign body and alters the 130 local hemodynamics. These three effects instigate and 131 influence four interacting biological processes which 132 can lead to re-narrowing of the stented artery, known 133 as ISR. ISR is defined as angiographic evidence of a 134 loss of greater than 50% of the lumen diameter post 135 intervention. 95 136 Structural injury is inflicted on the arterial wall 137 during the implantation procedure. The stent and 138 balloon denude most of the endothelium on contact, 139 exposing the underlying collagen fibres and leaving 140 some damaged endothelial cells (ECs) directly adjacent 141 to the stent struts. 116 Stent implantation stretches, and 142 therefore stresses, the arterial wall and as a result the 143 cellular structure of vascular smooth muscle cells 144 (VSMCs) present in the media can be disrupted, and 145 the internal elastic lamina (IEL) and the media can 146 rupture. Atherosclerotic lesions present at an implan-147 tation site are inelastic and frequently split rather than 203 Thrombus Formation 204 Thrombus formation, in general, is the body's 205 emergency response mechanism to structural injury 206 and entails primary and secondary haemostasis. Pri-207 mary haemostasis involves blood-borne platelets 208 quickly adhering to form a plug at an injury site.
209 Occurring in parallel with this is secondary haemo-210 stasis which involves the formation of fibrin fibres 211 through the coagulation cascade, and these fibrin fibres 212 bind the adhered platelets together at the injury site.
213 When structural injury is inflicted on an artery by 214 stent implantation, platelets present in the bloodstream 215 are activated by exposed collagen and plaque, and by 216 proteins expressed by damaged ECs (e.g., fibronectin 217 and von Willebrand factor (vWf)). Activated platelets 218 are more sensitive to chemical signals and adhere to the 219 collagen, plaque and proteins on the arterial wall, 220 changing their cytoskeleton (cell scaffolding) to 221 become more flexible and capable of spreading out 222 over the injury site. Activated platelets also release 223 platelet activating factor (PAF), adenosine diphos-224 phate (ADP) and thromboxane A2 into the blood-225 stream which in turn activate more platelets and aid in 226 the aggregation of platelets at an injury site. The 227 coagulation cascade involves several coagulation fac-228 tors present in the bloodstream and those released by 229 adhered platelets and leukocytes, and VSMCs (e.g., 230 tissue factor). Through the coagulation cascade pro-231 thrombin, present in the blood plasma, is converted to 232 thrombin which both activates more platelets and 233 causes soluble fibrinogen molecules in the blood plas-234 ma to convert into fibrin monomers. These fibrin 235 monomers form fibrin fibres that bind the platelets that 236 have aggregated together at the injury site, forming a 237 thrombus.
238 In addition to this response to structural injury, 239 thrombus formation is also initiated by the presence of 240 a foreign body. Blood-soluble proteins adsorb onto the 241 stent surface, forming a thin film which provides a 242 provisional matrix that controls the subsequent bio-243 logical processes of the foreign-body response. 1 Dif-244 ferent proteins (e.g., albumin, fibrinogen, fibronectin, 245 vitronectin and y-globulin) adsorb onto the stent sur-246 face depending on the properties of the surface mate-247 rial. 1 These adsorbed proteins produce different 248 effects; fibrinogen for example is pro-thrombotic, 249 promoting activation and adhesion of platelets, 250 whereas albumin reduces platelet adhesion and aggre-251 gation. 85 Fibrinogen is adsorbed preferentially over 252 other proteins on many surfaces, especially polymers, 85 253 and thus facilitates thrombus formation at a stent 254 implantation site.
255 Thrombus formation has been found to be heavily 256 flow dependent. The platelets, coagulation factors and tissue damage and infection, and to aid in wound 289 healing and tissue repair. 94 290 Structural injury to the arterial wall by stent 291 implantation triggers the expression of several cell 292 adhesion molecules which mediate four steps, shown in 293 Fig. 3 , that each leukocyte undergoes in order to 294 infiltrate an injury site. These four steps are the initial 295 contact (tethering), leading to rolling and activation of 296 the leukocyte, followed by firm adhesion and finally 297 transmigration into the arterial wall. Tethering and 298 rolling are mediated by cell adhesion molecules 299 P-selectin (expressed by adhered platelets and damaged 300 VSMCs) and E-selectin (expressed by damaged ECs) 301 which interact with ligands expressed on the leukocyte 302 surface. Firm adhesion is mediated by platelet glyco-303 protein (GP) Ib-b, vascular cell adhesion molecule 1 304 (VCAM-1) and intercellular adhesion molecule 1 305 (ICAM-1) expressed on the damaged wall, which 306 interact with integrins expressed on the surface of the 307 leukocytes, e.g., macrophage-1 antigen (MAC-1). The 308 final step is driven by concentration gradients of che-309 mokines (chemotactic cytokines) released by damaged 310 ECs and VSMCs, and by the leukocytes already pres-311 ent at the injury site. Neutrophil infiltration of the 312 injury site represents the initial acute phase of the 313 inflammatory response and they are present up to, but 314 not beyond, 30 days after BMS implantation. 36 The 315 chronic phase of the inflammatory response involving 316 lymphocyte and monocyte infiltration of the injury 317 site, extends from 3 days to beyond 6 months for 318 BMSs. 36 When monocytes migrate across the platelet/ 319 fibrin thrombus to the site of initial injury, they dif-320 ferentiate into macrophages. These cells consume the The thin layer of proteins adsorbed onto the 324 implanted stent surface not only mediates the adhesion 325 of platelets, but also controls the inflammatory phase 326 of the foreign-body response to the stent. The com-327 plement system, which consists of more than 20 plas-328 ma-based proteins, is a primary contributor to the 329 innate immune system and is activated by the adsorbed 330 protein layer. Activation of the complement system 331 promotes the formation of enzymes and binding pro-332 teins which regulate the inflammatory response to a 333 foreign body. Leukocytes, particularly neutrophils and 334 monocytes, follow increased concentration gradients 335 of chemo-attractant anaphylatoxins, such as C5a, 336 which are fragments produced by activation of the 337 complement system. Other products of complement 338 activation, such as C3b and iC3b, through a process 339 called opsonisation mark foreign particles for phago-340 cytic removal (ingestion) by leukocytes and subsequent 341 proteolysis (digestion) by proteases (cellular enzymes). 342 This is the case for any contaminants on the stent 343 surface; however, in the case of a relatively large for-344 eign body, such as a stent, which cannot be ingested, 345 adhered neutrophils and monocytes undergo a frus-346 trated phagocytosis whereby they release their array of 347 potent oxygen metabolites and proteolytic enzymes. 46 348 This can lead to an unresolved chronic inflammatory 349 response exemplified by the increased fusion of mac-350 rophages into foreign body giant cells around an 351 implanted stent. Platelets which adhere to the adsorbed 352 protein layer on stent struts also release P-selectin to 353 aid leukocyte adhesion and these adhered leukocytes 354 can also encourage thrombus formation through 355 elevated expression of tissue factor. 35 Products of the 356 complement system can interact with proteins involved 357 in thrombus formation and thus, can also regulate 358 each other. Metallic stent struts or the presence of a 359 polymer coating on a stent can induce an allergic 360 inflammatory reaction in some people, which is 361 observed as eosinophil activation and presence at the 362 implantation site. 105 363 The local hemodynamics can also mediate the 364 adhesion of leukocytes at an implantation site. With 365 increased thrombus formation due to the hemody-366 namics in certain regions, e.g., re-attachment areas 367 where flow is directed towards the arterial wall, there is 368 a greater amount of cell adhesion molecules available 369 to capture passing leukocytes. In addition to this, it has 370 been found that local vascular hemodynamics can 371 affect leukocyte ligand expression, 40 , shape 23 and 372 consequently interaction with other cells. 142 Leuko-373 cyte-EC interaction is heavily influenced by the local 374 hemodynamics which becomes more relevant as the 375 endothelium reforms over the implantation site. For 376 instance, leukocytes retract their pseudopodia (tem-377 porary projections from leukocytes used to adhere to a 378 surface) when exposed to nitric oxide (NO), 96 which is 379 produced by functioning ECs in response to physio-380 logical WSS (15 dyne/cm 2 ). 14 However, when ECs 381 are exposed to low WSS (<10-12 dyne/cm 2 ) or dis-382 turbed flow they decrease their expression of anti-383 inflammatory mediators (e.g., NO) and upregulate cell 384 adhesion molecules (e.g., E-selectin, VCAM-1 and 385 ICAM-1). Therefore, the establishment of normal 386 physiological blood flow within a stented artery fol-387 lowing the procedure is crucial to avoiding prolonged 388 inflammation and consequently possible ISR.
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Neointimal Hyperplasia 390 NIH takes place up to 18 months post-implanta-391 tion, results in a thickening of the intimal layer, and is 392 the main cause of ISR. NIH involves the migration 393 and proliferation of VSMCs originating in the media, 394 and also differentiating from fibroblasts in the adven-395 titia and bone-marrow-derived stem cells in the 396 bloodstream. In addition, the VSMCs synthesise 397 extracellular matrix (ECM). The degree of NIH is 398 heavily influenced by the degree of thrombus forma-399 tion and inflammation which takes place at an 400 implantation site. 401
Damaged ECs and VSMCs, adhered leukocytes and 402 platelets release cytokines (proteins used for intercel-403 lular communication) and mitogens (proteins which 404 encourage a cell to commence the cell-division cycle) 405 which encourage NIH at an injury site. The migration 406 of the VSMCs is stimulated by cytokines [e.g., tumor 407 necrosis factor (TNF) and interleukin-1 (IL-1)] released 408 by macrophages and also by some of the mitogens (e.g., 409 platelet-derived growth factor (PDGF)). PDGF is 410 capable of stimulating migration at a much lower 411 concentration level than that needed for cell division 48 412 and therefore, migration is an earlier response than 413 proliferation. In order for migration to occur enzymes 414 [e.g., matrix metalloproteinase (MMP)-9] released by 415 adhered leukocytes and VSMCs help in the dissolution 416 of the IEL and the existing ECM. This dissolution, 417 along with the disruption to the ECM caused by stent 418 implantation, allows the medial VSMCs and myofi-419 broblasts (activated fibroblasts) to migrate through to 420 the neointimal region of the arterial wall. The prolif-421 eration of VSMCs is instigated by mitogens [e.g., 422 serotonin, thromboxane A 2 , PDGF and basic fibro-423 blast growth factor (bFGF)] which are released by 424 damaged ECs and VSMCs, adhered leukocytes and 425 platelets. This proliferation produces a greater amount 426 of neointimal cells than does migration. In addition to 427 VSMC migration and proliferation, inflammatory and 428 hematopoietic cytokines [e.g., granulocyte colony-429 stimulating factor (G-CSF)] produced by ECs and 430 leukocytes at the injury site mobilise stem cells from the 431 bone marrow to enter the bloodstream. 68,69 These stem 432 cells can differentiate into smooth muscle progenitor 433 cells (SPCs), which adhere to fibronectin and differen-434 tiate into VSMC-like cells in the presence of PDGF-BB 435 (a PDGF isoform) at the injury site. 53, 131 The stretching 436 of the original VSMCs in the arterial wall stimulates 437 them to synthesise collagen, a component of ECM, 438 which may serve to alleviate the additional stress 439 caused by stent implantation, but also increases the 440 overall wall volume. 84 This, along with the synthesis of 441 ECM by neointimal VSMCs can contribute up to 80% 442 of the resultant wall thickening. 44 443 Leukocytes and platelets attracted to a foreign body 444 can also release cytokines and mitogens which 445 encourage NIH. Macrophages activated by biomedical 446 polymers in vitro have been shown to stimulate fibro-447 blast activity. 1 In addition to this, macrophages and 448 foreign-body giant cells on a biomaterial surface 449 modulate ECM fibrosis. This results in the formation 450 of a fibrous capsule, mainly comprised of collagen 451 fibres and leukocytes, which isolates the stent from the 452 surrounding tissue and blood. 1 453 NIH can also be induced and influenced by local 454 hemodynamics within the stented arterial region.
455 Where local hemodynamics cause increased thrombus 456 formation and inflammation, due to the release of 457 mitogens by adhered leukocytes and platelets, this 458 subsequently induces increased NIH. In regions where 459 the endothelium has been denuded and the IEL dam-460 aged by stent implantation, underlining VSMCs may be 461 exposed and affected by the local hemodynamics.
462 Human VSMCs exposed to physiological or high WSS 463 (14 and 28 dyne/cm 2 respectively) for 24 h show an 464 increase in transforming growth factor (TGF)-1 expres-465 sion which inhibits their proliferation, in comparison 466 with a static control. 148 High WSS (>15 dyne/cm 2 ) also 467 stimulates the release of stored mitogens (PDGF and 468 bFGF) within VSMCs into the bloodstream while low 469 WSS increases VSMC susceptibility to these mito-470 gens. 135 Thus, in a stented artery where there is vari-471 ability between high and low WSS across the stent and 472 arterial wall, increased proliferation would occur in low 473 WSS zones. 101 In addition, pulsatile turbulent WSS has 474 also been found to stimulate VSMC proliferation, 129 475 and murine VSMCs exposed to steady laminar WSS of 476 15 dyne/cm 2 have been found to transdifferentiate into 477 ECs. 152 Within the arterial wall, VSMCs and myofi-478 broblasts are exposed to transmural interstitial shear 479 stress which can be increased by endothelium denuda-480 tion, activating these cells and promoting their migra-481 tion into the intima or wound site. 127 ECs present in the 482 stented region downregulate anti-proliferative gene 483 expression and upregulate the release of VSMC growth 484 factors in response to low WSS. 14 The oxygen flux from 485 the blood into the arterial wall, which is also heavily 486 flow dependent, has also been found to influence 487 VSMC behaviour. NIH has been found to be reduced 488 in rabbits treated with supplemental oxygen, 83 Author Proof
495 permeability barrier, participation in cardiovascular 496 homeostasis and inflammatory responses, regulation of 497 cellular growth and proliferation within the arterial 498 wall, angiogenesis and tumour metastasis. 121 Consid-499 ering its importance, once denudation by stent 500 implantation has occurred, its reinstatement, i.e., 501 re-endothelialisation, is critical in order for the artery 502 to return to its normal functioning behaviour. 503 Damaged ECs, adhered platelets, VSMCs and 504 macrophages present at the injury site release mitogens 505 capable of instigating re-endothelialisation. These 506 mitogens include vascular endothelial growth factor 507 (VEGF), PDGF and bFGF and induce the ECs 508 remaining around the stent struts and outside the 509 stented area to migrate and proliferate into the 510 denuded section. In addition, increased levels of VEGF 511 circulating in the bloodstream induce precursors of 512 endothelial cell colony forming units (EC-CFUs) 513 (angiogenic monocytes and lymphocytes) and endo-514 thelial progenitor cells (EPCs) derived from bone 515 marrow stem cells, to mobilise, enter the bloodstream 516 and home in on the injury site. It has been hypothe-517 sised that EC-CFUs precursors arrive earlier than 518 EPCs to provide rapid coverage of the injury site and 519 secret angiogenic factors (e.g., VEGF and G-CSF) 520 which encourage EPC homing and proliferation. 106 521 EPCs attach to proteins and adhesion molecules on the 522 arterial wall and subsequently differentiate into mature 523 ECs. 524
ECs or EPCs will not adhere directly to, or prolif-525 erate over, a normal stent surface 25 and as such 526 re-endothelialisation over the stent struts cannot occur 527 without an adsorbed protein layer and adhesion mol-528 ecules expressed by cells adhered to the surface. Some 529 stent designs endeavour to promote re-endothelialisa-530 tion by applying coatings to the stent surface. 5, 25, 128 531 The surface texture of a stent also influences 532 re-endothelialisation and thus some new stents are 533 exploring different surface modifications which may 534 aid re-endothelialisation. 6 In addition to this the sur-535 face chemical composition also affects re-endotheliali-536 sation, e.g., endothelial migration onto stainless steel 537 via interaction with adsorbed fibrinogen is significantly 538 greater than that observed onto gold surfaces. This 539 could be due to the surface charge, hydrophobicity, or 540 chemical composition of the surface material. 133 541
Local hemodynamics at a stent implantation site 542 also have an effect on the initial and continued 543 adherence of ECs and EPCs. Large WSS oscillations 544 over positive and negative values, i.e., 1 Hz reversing 545 sinusoidal WSS of mean 20 dyne/cm 2 with an ampli-546 tude of 40 dyne/cm 2 , has been found to cause the 547 detachment of cultured bovine aortic ECs, 58 which 548 would delay re-endothelialisation. ECs have been 549 shown to migrate downstream of an area where the 550 WSSG is above 30 dyne/cm 3 . 24, 145 The migration of 551 ECs into denuded areas from adjacent areas with an 552 intact endothelium has been shown to be increased 553 when exposed to undisturbed laminar flow as 554 opposed to disturbed laminar flow or static flow. 66 555 Re-endothelialisation of the stent surface has also been 556 found to be WSS dependent, with low WSS regions 557 experiencing delayed re-endothelialisation and high 558 WSS encouraging EC migration onto stent surfaces. 132 559 In addition to this, as the healing process progresses 560 and the endothelium layer reforms, ECs can sense and 561 are responsive to WSS conditions. In physiological 562 flow conditions ECs align themselves in the flow 563 direction and are in an atheroprotective state, releasing 564 anticoagulants, antioxidants and vasodilators such as 565 NO. When ECs are in regions of low WSS or high 566 WSSG they switch to an atherogenic state in which 567 they adopt a cobblestone shape in a more random 568 arrangement, shown in Fig. 4 , no longer aligned with 569 the flow and presenting gaps in the endothelial layer, 570 thus encouraging cellular and lipid infiltra-571 tion. 110, [118] [119] [120] In this form they also up-regulate 572 inflammatory mediators, adhesion molecules, pro-573 coagulant and pro-thrombotic agents, and VSMC 574 growth factors, all of which can lead to increased NIH 575 and result in ISR. 87
576
The Influence of Stent Design on ISR
577
There are many different stents available on the 578 market with varying strut configurations, thicknesses, 579 materials, and deployment mechanisms, and in the 580 case of DESs different coatings, drug types, doses and 581 drug release kinetics. These varying designs produce 582 different degrees of structural injury, foreign-body 583 reactions and hemodynamic flow field alterations, 584 which in turn affect the biological processes taking 585 place within the stented artery and the resultant ISR 586 rates. A study by Kastrati et al. 74 of 3,370 patients 587 (4,229 stented lesions) who underwent angioplasty 588 with stenting using different BMS types concluded that 589 following vessel size, stent design was the second 590 strongest factor in determining the occurrence of ISR. 591 The structural injury caused by stent implantation 592 to the arterial wall is assumed to be proportional to the 593 stress induced within the wall, which is dependent, in 594 part, upon the stent design. Self-expanding stents have 595 been found to cause less injury to the endothelium than 596 balloon-expandable stents, because only the stent 597 struts, in contrast with both the struts and an expanded 598 balloon, are in contact with the arterial wall. 54 The 599 injury caused by the balloon depends on the inflation 600 pressure, stent geometry and distance between 601 struts. 117 Author Proof
603 have been studied using finite element analysis and are 604 hypothesised to affect the degree of injury inflicted 605 upon the arterial wall. High stresses within the arterial 606 wall can cause increased damage, and in the case of 607 medial injury and lipid core penetration by stent struts 608 there is a propensity for increased inflammation. 36 By 609 reducing the number of strut-strut intersections by one 610 third, disruption of the IEL and the media layer were 611 reduced by nearly one half in a study of steel stents 612 deployed in denuded rabbit iliac arteries. 115 Several 613 clinical studies have linked the degree of arterial wall 614 prolapse between stent struts with the occurrence of 615 ISR. 61, 70, 111 The amount of prolapse between stent 616 struts is also dependent on the strut spacing. Following 617 implantation, a stent must also be able to withstand 618 additional stresses placed upon it from vessel defor-619 mation. In the case of coronary arteries the beating of 620 the heart causes slight movements and deformations of 621 the arteries. [26] [27] [28] Also, in peripheral arteries, such as 622 the femoral, popliteal and tibial arteries, deformation 623 is caused by the flexion of the hip, knee or ankle, which 624 in some cases can cause fracture of an implanted stent 625 possibly resulting in renewed injury to the arterial wall 626 and ISR. 123 Therefore, not only does the stent design 627 have an effect on the structural injury inflicted on the 628 arterial wall initially, but the properties of the stent 629 material and its ability to withstand cyclic loading of 630 the heart beating or a limb moving can also affect the 631 probability of ISR occurring during the lifetime of a 632 stent. 633
The stent material also has implications on each 634 biological process in the response to a foreign body. 635 Stainless steel, used in most BMSs, is found to oxidise 636 in the body causing varying degrees of cell toxicity. 156 637 First-generation DES permanent polymer coatings 638 were found to cause delayed healing, impaired stent 639 strut endothelialisation, and hypersensitivity reactions, 640 which can culminate in stent thrombosis in some 641 cases. 42, 72, 73, 103, 149, 151 In a study of different DESs 642 implanted in rabbits by Joner et al. 73 it was found that 643 struts lacking endothelial coverage at 14 days showed 644 focal aggregates of platelets and inflammatory cells, 645 including foreign body giant cells. Therefore, in the 646 absence of complete endothelialisation of polymeric 647 strut surfaces increased inflammation and thrombus 648 formation may result. New DES coatings such as 649 phosphorycholine and the co-polymer poly(vinylidene 650 fluoride-co-hexafluoropropylene) mimic the phospho-651 lipids on the outer surfaces of red blood cells. 92 This 652 improves the biocompatibility of the DES by masking 653 its foreign nature. As a result of the observed detri-654 mental effects of permanent polymers implanted in the 655 body, biodegradable polymer coatings and completely 656 polymer free stents are also being developed. 43 657 The resultant local hemodynamics created within 658 the stented lumen are also partially dependent on the 659 stent design. Thrombus formation, as mentioned pre-660 viously, is heavily flow dependent with highest platelet 661 deposition occurring where flow is directed towards the 662 arterial wall. 33 Monocyte adhesion rates were found to 663 be affected by not only the local WSS, but also the 664 radial component of velocity and the dynamics of the 665 recirculation region and flow reattachment. 112 Flow 666 separation away from the arterial wall and recircula-667 tion zones occur both upstream and downstream of 668 rectangular cross-sectional stent struts. Platelets within 669 these zones experience long particle residence times in 670 proximity to activating substances, which increases 671 their probability of activation. With thinner and more 672 streamlined stent struts, the recirculation zones, and 673 also consequently, the particle residence times can be 674 reduced. 71 WSS, WSSG and WSSAG within an idea-675 lised stented artery can be predicted using computa-676 tional fluid dynamics (CFD) and different stent designs 677 have been shown to produce significantly different 678 distributions of each. 81, 82, 101 The angle that stent struts 
692
CFD analyses, in vivo and in vitro studies have been 693 used to assess the effects of stent implantation on the 694 local hemodynamics. 33, 34, 57, 80, 81, 101 These studies con-695 centrate on existing stents which fulfil the basic role as 696 a scaffold to keep an artery open. Novel complemen-697 tary devices and stent designs have been, and are cur-698 rently being, developed which not only re-establish 699 blood-flow in an obstructed artery but establish 700 hemodynamics which inhibit ISR.
701
ARED Flow Divider
702
The Anti-Restenotic Diffuser (ARED) flow divider, 703 as shown in Fig. 5 , was developed on the premise that 704 increasing the WSS in a stented artery decreases the 705 risk of developing excessive IH, resulting in ISR. The 706 device was patented by Dr Nikolaos Stergiopulos of 707 the Ecole Polytechnique Federale de Lausanne (EPFL) 708 in Switzerland in 2000 (European Patent EP0989830). 709 The concept behind the ARED flow divider is that, 710 upon insertion within the stented region, self-expand-711 ing appendages which press against the arterial wall 712 hold a central solid cylinder along the artery's central 713 axis. The overall cross sectional area of the artery is 714 thus reduced, as shown in Fig. 6, thereby , and implanted with both a MultiLink stent 735 along with an ARED flow divider in another. CFD was 736 used to estimate the alteration of WSS in the stented 737 artery due to the presence of the ARED flow divider 738 using two idealised tubes: one with a centrally-located 739 cylinder (approximating the segment with the ARED 740 flow divider) and one without (approximating control 741 segment). The increase in WSS (from 3.8 to 8.2 dyne/cm 2 742 as predicted by the idealised CFD analysis), caused by 743 the presence of the ARED flow divider in comparison 744 to the control segment, resulted in local reductions in 745 injury and inflammation score, and NIH following 746 stent implantation. Based on this observation, Carlier 747 et al. 8 concluded that this study supports the hypothesis 748 that increasing the WSS within a stented region can 749 lead to decreased accumulation of macrophages, pre-750 venting IEL dissolution and subsequent VSMC 751 migration within that region. Histological cross sec-752 tions obtained in the study are shown in Fig. 7 . 753 Sanmartin et al. assessed the influence of WSS on 754 ISR using a combination of angiography and intra-755 vascular ultrasound of the right coronary artery of 756 seven patients following stent implantation, along with 757 the results from CFD analyses of reconstructed 758 geometries of the implanted arteries. In this study, an 759 inverse relationship was found between WSS and NIH; 760 however, it was noted that the conclusions drawn from 761 the study by Carlier et al. 122 should not be extrapolated 762 directly to humans, given that flow conditions, vascu-763 lar geometry and response to lesions are very different 764 in humans compared with rabbits. 765 The ARED flow divider was never implanted in 766 humans 77 ; however, these studies demonstrate that 767 local WSS distribution could influence NIH and there 768 was a potential application of this fact in the design of 769 new vascular devices. FIGURE 5. ARED flow divider for insertion in a stented artery. It is held in place by the self-expanding appendages radiating out from the central cylinder which press against the arterial wall. 8
Helical Flow Devices
771
The local hemodynamics have a significant influence 772 on the cellular activity within an arterial wall. Ath-773 erosclerosis has been found to preferentially develop in 774 areas of disturbed flow and regions of low 775 WSS. 12, 14, 17, 79, 136 Natural blood flow in the arterial 776 system has been found to be helical in nature. The 777 beneficial/detrimental implications of helical flow in 778 the cardiovascular system are open to conjecture. 47 779 However, two novel stent designs are being developed 780 that endeavour to elicit helical flow and take advantage 781 of its beneficial characteristics in terms of inhibiting 782 atherosclerotic lesion development and ISR.
Helical Flow
784
Experiments conducted by Caro 9 on the dispersion 785 of indicator flowing in simplified models of the circu-786 latory system showed that large secondary motions 787 were induced by bends in the models. It was postulated 788 that these secondary motions had particular physio-789 logical importance in circulation, listing possible 790 advantages as being the prevention of stagnation zones 791 and flow separation at the arterial walls. Fig. 8 along with a sample 803 ultrasound image. 141 804 The terms spiral flow and helical flow are used 805 interchangeably in the literature, but for the purpose of 806 this paper, helical flow is the term used. The helical 807 flow in arteries is induced by their non-planar curva-808 ture and the heart itself. It has been proposed that the 809 secondary motion, i.e., the rotational motion, of the 810 blood flow is induced by the twisting of the left ven-811 tricle during contraction, 91 and then accentuated upon 812 entering the aortic arch. 39, 75 This twisting is, in part, 813 due to the structure of the ventricular myocardial band 814 of the heart which has been found by Torrent-Guasp 815 to be spatially orientated in the form of a helix. 147 816 Brecher 7 also observed that there existed a continuous 817 negative pressure within the ventricle which Marinelli 90 818 cited as evidence of a perpetual vortex within the 819 ventricle, which provides the ventricular suction during Many of the beneficial effects of helical flow in the 838 arteries were originally only postulations by 839 researchers in the area; however, there is growing evi-840 dence which support these postulations. Stonebridge 841 et al. 141 discuss how there are theoretical advantages to 842 helical flow, including rotationally-induced stability, 843 reduced turbulence, and a beneficial effect on mecha-844 nisms of endothelial damage. A paper by Caro et al. 11 845 it was highlighted that greater mixing and more uni-846 form WSS was expected in the cardiovascular system 847 which was found to be commonly non-planar. Doorly 848 et al. 29 found through CFD analysis that a simple 849 modification to the geometry of an end-to-side anas-850 tomosis, where the graft is rendered approximately 851 helical, produced a profound effect on the flow, 852 enhancing the swirling motion of the flow downstream. 853 Zabielski and Mestel 157 concluded from a CFD anal-854 ysis into helical flow around arterial bends that the 855 non-planar curvature limits the severity of flow sepa-856 ration at the inner bend and reduces variation of the 857 WSS. This was confirmed in a CFD analysis by 858 Papaharilaou et al. 108 of planar and non-planar 859 end-to-side anastomoses where it was found that the 860 introduction of an out-of-plane curvature produced a 861 significant change in the spatial distribution of WSS 862 and a 10% reduction in the time-averaged peak WSS 863 magnitude. The spatial extent of the elevated oscilla-864 tory WSS regions was reduced in the non-planar model 865 in comparison with the planar model and given that 866 Ku et al. 79 found a correlation between elevated 867 oscillatory WSS and NIH there are effectively less 868 areas exposed to unfavourable, in terms of disease 869 progression or ISR, flow conditions in the non-planar 870 geometry. In a numerical study of vortical flow iden-871 tification and flow transport in arterial graft geome-872 tries, Doorly et al. 30 found that significant greater 873 particle mixing was prevalent in the non-planar 874 geometry compared with the planar geometry, with 875 continual transport of particles away from the wall, 876 thus lessening near-wall particle residence times. 877 Stonebridge et al. 140 compared helical and non-helical 878 flow patterns through stenoses using MRI in vitro and 879 CFD modelling. In this study it was found that near-880 wall turbulence energy was up to 700% less with 881 helical flow than non-helical flow beyond the stenosis, 882 with turbulence being associated with substantial WSS 883 fluctuations in both space and time. 89 The degree of 884 helical flow has been found by Houston et al. 63 to be 885 reduced in atherosclerotic arteries, although a direct 886 relationship between atherosclerotic lesions and the 887 absence of helical flow has not been proven, and within 888 these arteries the turbulent nature of the resulting flow 889 encourages further development of the disease. A study 890 by Morbiducci et al. 98 indicated that helical flow 891 dampened WSS temporal gradients in aortocoronary 892 bypass grafts. Morbiducci et al. 100 also conducted an 893 in vivo investigation into the helical flow patterns in the 894 aortic region of five healthy humans using 4D phase-895 contrast MRI, and CFD analyses of the reconstructed 896 aortic geometries. It was found that helical-blood-flow 897 dynamics is common to healthy individuals, and that An analysis by Paul and Larman 109 using CFD of 922 helical flow downstream of a 75% stenosis found that 923 turbulent kinetic energy was reduced post stenosis. The 924 helical motion provides rotational stability to the flow, 925 reducing flow disturbance and turbulence, which is a 926 beneficial effect. Conversely, as noted by Paul and 927 Larman, 109 helical flow also produced oscillating WSS 928 in the post-stenosis model, which is considered a det-929 rimental effect possibly causing damage to the endo-930 thelium. In addition to this, other researchers have 931 speculated on whether the effects of helical flow are 932 entirely beneficial. Frazin et al. 38 considered that 933 although the rotational element of the flow may be 934 important physiologically for organ perfusion, patho-935 logically, there may be a relation between the shear 936 forces induced by helical flow and plaque deposition. A 937 paper by Texon 146 showed that ''serpentine flow'' in 938 relatively straight vessels may also produce zones of 939 diminished lateral pressure and atherosclerosis. A 940 CFD study of helical grafts by Zheng et al. 159 found 941 that along with the benefits of increased WSS and 942 swirling flow, there was also an enlarged pressure drop 943 and low velocity concentrated in one area in a helical 944 graft model which could lead to increased NIH or 945 thrombosis. Pressure drop was found to be propor-946 tional to the helicity of an inlet flow into an idealised 947 stented artery in a CFD study by Chen et al. 15 CFD 948 simulations conducted in this study showed pressure 949 drops for the stent with swirling flow to be 164, 167 950 and 173 Pa for inlet helicities of 3.5, 6.4 and 14.5 m/s 2 , 951 respectively, whereas for the stent with normal inlet 952 flow the pressure drop was 163 Pa. Beneficial effects of 953 helical flow also noted in this paper were that the 954 average lengths of the recirculation zones between the 955 stent struts and oscillatory shear index (OSI), a mea-956 sure of the change in direction and magnitude of the 957 WSS vectors during the cardiac cycle, were reduced 958 with increasing helicity of the inlet flow, which 959 enhanced the average WSS in comparison with normal 960 flow. 15 961 Considering the correlation between adverse flow 962 conditions and increased NIH 3, 45, 55, 59, 76, 107 and the 963 effects of the local hemodynamics on the other bio-964 logical processes leading to ISR, discussed in ''In-Stent 965 Resteno'' section, there are two particular stents which 966 are embracing the beneficial effects of helical flow, i.e., 967 increasing particle mixing, reducing areas of disturbed 968 flow and providing a more uniform WSS, and 969 endeavour to restore this natural blood flow pattern in 970 a stented artery.
971
BioMimics 3D [139] [140] [141] into the naturally 1120 occurring helical flow found in studies of the cardio-1121 vascular system using Doppler ultrasound, as men-1122 tioned previously. The benefits of helical flow, 1123 discussed earlier, led VFT to design a bypass graft, Cookson et al. 20 in a CFD analysis of the mixing behaviour in a helical pipe with two different helical geometries.
1166
designed to mimic lesions that may occur downstream 1167 of a stent and to induce cell proliferation and ECM 1168 synthesis, both of which contribute to neointimal 1169 thickening. There was a statistically significant reduc-1170 tion in intima/media ratios distal to the implanted 1171 region in the modified stent porcine models, with a 1172 high ratio indicating significant neointimal thickening, 1173 in comparison with the control stent porcine models. 1174 Using Doppler ultrasound it was confirmed that the 1175 modified stent maintained the natural helical flow 1176 within the arteries of all eight pigs, whereas, the control 1177 stent did not. An idealised plain-wall tube was com-1178 pared with a tube with a helical ridge using CFD and 1179 results obtained predicted a reduction in turbulent 1180 kinetic energy downstream of a 50% stenosis in the 1181 helical-ridge model.
DISCUSSION
1183
There are many factors which influence the biological 1184 processes that can result in ISR. The local hemodynamics FIGURE 13. Axial and longitudinal views of the proposed helical-ridge insert for stents, adapted from European Patent EP1314406 (B1). 65 FIGURE 14. Graph taken from US Patent US7721767. The variation of non-dimensional pressure drop with the helix angle is notated as 50 and the variation of non-dimensional turbulent kinetic energy with the helix angle is notated as 51. The helix angle when both variables are equal to zero is notated as 52. 64 
